Results 211 to 220 of about 230,623 (311)

The extent of androgen receptor and HER2 expression allows for targeted therapy in most cases of salivary duct carcinoma: analysis of clinical and histopathological data in a tertiary care center [PDF]

Marcel Mayer, Philipp Wolber, Johanna Prinz, Louis Jansen, Julia Eßer, Sami Shabli, Alexander Quaas, Jens Peter Klußmann, Shachi Jenny Sharma, Lisa Nachtsheim, Christoph Arolt   +10 more
openalex   +1 more source

Comparative Digital Estrogen Receptor Alpha (ERα) Expression Analysis in Benign and Malignant Prostate Tissue of Men and Dogs

The Prostate, EarlyView.
ABSTRACT Background The dog is the only large mammal, other than humans, that commonly develops spontaneous prostate cancer (PCa) and is, therefore, considered a valuable model for comparative studies. Estrogens are critical for normal prostate development and contribute to prostatic carcinogenesis in men.
Jennifer Lothion‐Roy, Leonore Aeschlimann, Lea Anna Hiller, Sven Rottenberg, Nigel P. Mongan, Catrin S. Rutland, Emad Rakha, Alexander Dean, Mark A. Rubin, Simone de Brot   +9 more
wiley   +1 more source

Coregulators determine androgen receptor activity in prostate cancer. [PDF]

Biosci Rep
Yavuz K, Lack NA.
europepmc   +1 more source

Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High‐Risk Metastatic Hormone‐Naïve Prostate Cancer: Results From a 3‐Year Interim Analysis of the J‐ROCK Study

The Prostate, EarlyView.
ABSTRACT Introduction In real‐world practice in Japan, standard treatment for metastatic hormone‐naïve prostate cancer (mHNPC) is androgen deprivation therapy (ADT), administered as monotherapy, combined androgen blockade (CAB), ADT plus androgen receptor pathway inhibitors (ARPIs), or ADT plus docetaxel.
Atsushi Mizokami, Rikiya Matsumoto, Hideaki Miyake, Hiroji Uemura, Hirotsugu Uemura, Satoru Kawakami, Kazuyoshi Nakamura, Shigekatsu Maekawa, Hiroaki Tsuchiya, Sachie Okazaki, Eri Adachi, Ryo Yano, Yohei Tajima, Kiyohide Fujimoto, Hideyasu Matsuyama   +14 more
wiley   +1 more source

Androgen receptor-mediated regulation of BRCA1 modulates the antioxidant defense in prostate cancer. [PDF]

J Pathol
Sriraman S, Virtanen V, Kukkula A, Toriseva M, Lumiainen A, West G, Poutanen M, Taimen P, Sundvall M.   +8 more
europepmc   +1 more source

A sample size analysis of a mathematical model of longitudinal tumor volume and progression‐free survival for Bayesian individual dynamic predictions in recurrent high‐grade glioma

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 495-509, March 2025.
Abstract Patients with recurrent high‐grade glioma (rHGG) have a poor prognosis with median progression‐free survival (PFS) of <7 months. Responses to treatment are heterogenous, suggesting a clinical need for prognostic models. Bayesian data analysis can exploit individual patient follow‐up imaging studies to adaptively predict the risk of progression.
Daniel J. Glazar, Solmaz Sahebjam, Hsiang‐Husan M. Yu, Dung‐Tsa Chen, Menal Bhandari, Heiko Enderling   +5 more
wiley   +1 more source

Correction: Adverse events of androgen receptor pathway inhibitors in prostate cancer from real world data. [PDF]

PLoS One
Lee J, Song M, Leem S, Kim JY, Shim SR, Kim JH, Chung BI.   +6 more
europepmc   +1 more source

Determinants of Receptor- and Tissue-Specific Actions in Androgen Signaling [PDF]

, 2015
Päivi Pihlajamaa, Biswajyoti Sahu, Olli A. Jänne   +2 more
openalex   +1 more source

Evaluation of Potential Hormonal Activities of Ashwagandha (Withania somnifera)

Phytotherapy Research, EarlyView.
ABSTRACT Ashwagandha is a widely used herb in traditional medicine systems, particularly Ayurveda. Despite its extensive tradition, growing concerns regarding its potential endocrinological effects have prompted scientific scrutiny. This review systematically evaluates the current preclinical, clinical, and case study evidence concerning AS's effects ...
Günter Vollmer, Thomas Brendler
wiley   +1 more source

Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor Outcomes. [PDF]

Cancers (Basel)
Plage H, Biernath N, Furlano K, Weinberger S, Jeutner J, Fendler A, Roßner F, Schallenberg S, Elezkurtaj S, Kluth M, Lennartz M, Marx AH, Samtleben H, Fisch M, Rink M, Slojewski M, Kaczmarek K, Koch S, Adamini N, Minner S, Simon R, Sauter G, Zecha H, Ecke T, Schlomm T, Horst D, Ralla B.   +26 more
europepmc   +1 more source